14 /100
LOW RISK
Score updated Apr 28, 2026

BCRX

BioCryst Pharmaceuticals, Inc. — Stock Dilution Tracker

Track BCRX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track BCRX — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
7
⚠️ Warrant Exposure
15
🔄Convertible Debt
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for BCRX.
🔔 Track BCRX — Get forecast alerts →
💹 Market Data
Market Cap$2.25B
Shares Outstanding254.11M
Float218.18M
Cash$274.75M
Debt$477.33M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 6.9% shares (2025Q4 vs prior)
276 institutional holders · 214.09M shares
#1 VANGUARD GROUP INC 22.27M shares
#2 BlackRock, Inc. 21.14M shares
#3 RA CAPITAL MANAGEMENT, L.P. 15.83M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest38.53M
Days to Cover8.0
% of Float17.7%
FINRA data as of Apr 15, 2026
📁 Recent SEC Activity
xbrl XBRL WARRANT Dec 31, 2020
4 INSIDER TRANSACTION Apr 07, 2026
3 FORM3 Apr 07, 2026
4 INSIDER TRANSACTION Mar 24, 2026
4 INSIDER TRANSACTION Mar 18, 2026
Full SEC filing analysis available with free account
📰 Recent News
No recent news
Track BCRX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BCRX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for BCRX
📊 BCRX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 BCRX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.